COVID-Net Biochem: An Explainability-driven Framework to Building
  Machine Learning Models for Predicting Survival and Kidney Injury of COVID-19
  Patients from Clinical and Biochemistry Data
  Ever since the declaration of COVID-19 as a pandemic by the World Health
Organization in 2020, the world has continued to struggle in controlling and
containing the spread of the COVID-19 pandemic caused by the SARS-CoV-2 virus.
This has been especially challenging with the rise of the Omicron variant and
its subvariants and recombinants, which has led to a significant increase in
patients seeking treatment and has put a tremendous burden on hospitals and
healthcare systems. A major challenge faced during the pandemic has been the
prediction of survival and the risk for additional injuries in individual
patients, which requires significant clinical expertise and additional
resources to avoid further complications. In this study we propose COVID-Net
Biochem, an explainability-driven framework for building machine learning
models to predict patient survival and the chance of developing kidney injury
during hospitalization from clinical and biochemistry data in a transparent and
systematic manner. In the first "clinician-guided initial design" phase, we
prepared a benchmark dataset of carefully selected clinical and biochemistry
data based on clinician assessment, which were curated from a patient cohort of
1366 patients at Stony Brook University. A collection of different machine
learning models with a diversity of gradient based boosting tree architectures
and deep transformer architectures was designed and trained specifically for
survival and kidney injury prediction based on the carefully selected clinical
and biochemical markers.
